Harvard Bioscience, Inc.

DB:HBI0 Stock Report

Market Cap: €23.6m

Harvard Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:HBI0 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Mar 26Buy€42,238Stephen DeNelskyIndividual10,000€4.22
17 Mar 26Buy€89,855William SniderIndividual21,000€4.33
16 Mar 26Buy€21,819John DukeIndividual5,000€4.36
16 Mar 26Buy€21,775Mark FrostIndividual5,000€4.36

Insider Trading Volume

Insider Buying: HBI0 insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of HBI0?
Owner TypeNumber of SharesOwnership Percentage
Private Companies27,0520.6%
Individual Insiders290,9096.45%
Hedge Funds660,19714.6%
Institutions1,293,36128.7%
General Public2,238,69849.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 49.26% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.54%
AMH Equity, Ltd.
340,160€1.8m0%1.61%
7.1%
Weber Capital Management, LLC
320,037€1.7m0%1.69%
4.61%
James Green
207,756€1.1m0%no data
3.98%
Acadian Asset Management LLC
179,614€939.1k1.33%no data
3.62%
Vanguard Capital Management, LLC
163,313€853.8k0%no data
2.77%
Corsair Capital Management, L.P.
124,810€652.5k12.6%0.11%
2.63%
Meros Investment Management, LP
118,522€619.7k-2.66%0.28%
2.61%
Nano-Cap New Millennium Advisors, Llc
117,500€614.3k95.8%0.51%
2.53%
Two Sigma Investments, LP
114,117€596.6k12.7%no data
2.25%
Renaissance Technologies LLC
101,427€530.3k-0.68%no data
1.38%
BlackRock, Inc.
62,226€325.3k0%no data
1.32%
Geode Capital Management, LLC
59,511€311.1k29.2%no data
1.09%
Acuitas Investments, LLC
49,109€256.8k0%0.1%
1.03%
Millennium Management LLC
46,332€242.2k-15.2%no data
0.69%
Katherine Eade
31,112€162.7k0%no data
0.61%
Vanguard Fiduciary Trust Company
27,730€145.0k-0.22%no data
0.6%
Williams & Novak Wealth Management, LLC
27,052€141.4k-22.4%no data
0.6%
Essex Investment Management Company, LLC
27,021€141.3k46.3%0.02%
0.53%
Jane Street Group, LLC
23,830€124.6k-42.6%no data
0.47%
William Snider
21,000€109.8k0%no data
0.35%
RBF Capital LLC
16,000€83.7k0%no data
0.33%
State Street Global Advisors, Inc.
14,932€78.1k-0.02%no data
0.23%
BNY Asset Management
10,230€53.5k-19%no data
0.22%
Stephen DeNelsky
10,000€52.3k0%no data
0.19%
Jennifer Cote
8,541€44.7k32.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/10 09:28
End of Day Share Price 2026/03/13 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Harvard Bioscience, Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raymond MyersBenchmark Company
Bruce JacksonBenchmark Company
Paul KnightBrean Capital Historical (Janney Montgomery)